Tardive Myoclonic Dyskinesia Responsive to Sodium Oxybate. 2018

Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori

Hyperkinetic movement disorders may be difficult to treat, but cases where patients respond to alcohol and/or drugs with similar effects have been described. We report the case of a 64-year-old man with tardive dyskinesia characterized by severe uncontrolled dystonic and myoclonic jerks of the face, shoulders, and arm and forearm muscles, which improved with oral sodium oxybate. Our case suggests the possibility to test sodium oxybate in patients with severe, drug-resistant hyperkinetic syndromes, especially when they are known to improve with alcohol.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071057 Tardive Dyskinesia Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE). Tardive Dystonia,Dyskinesia, Tardive,Dyskinesias, Tardive,Dystonia, Tardive,Dystonias, Tardive,Tardive Dyskinesias,Tardive Dystonias
D012978 Sodium Oxybate The sodium salt of 4-hydroxybutyric acid. It is used for both induction and maintenance of ANESTHESIA. 4-Hydroxybutyrate Sodium,Oxybate Sodium,Sodium Oxybutyrate,Sodium gamma-Hydroxybutyrate,gamma-Hydroxybutyrate,Somsanit,Xyrem,4 Hydroxybutyrate Sodium,Oxybate, Sodium,Oxybutyrate, Sodium,Sodium gamma Hydroxybutyrate,gamma Hydroxybutyrate
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
May 2008, The Journal of clinical psychiatry,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
July 2018, The Australian and New Zealand journal of psychiatry,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
December 1994, Journal of clinical psychopharmacology,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
March 1984, The Medical journal of Australia,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
July 1978, The British journal of psychiatry : the journal of mental science,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
February 1979, The British journal of psychiatry : the journal of mental science,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
November 1979, The Journal of clinical psychiatry,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
April 1998, Neurology,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
August 1976, The British journal of psychiatry : the journal of mental science,
Andrea Maria DʼArrigo, and Laura Campiglio, and Chiara Casellato, and Chiara Gambini, and Daniela Belvedere, and Manuela Secchi, and Chiara Rosci, and Alberto Priori
January 1986, Indian journal of psychiatry,
Copied contents to your clipboard!